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Introduction
The nuclear envelope (NE) was historically viewed as little more 
than a physical barrier, like the walls of a mediaeval city (Fig. 1). 
Such cities typically had a double wall or moat for protection and 
accordingly the NE is comprised of two separate lipid bilayers, 
the inner and outer nuclear membranes (INM and ONM) with 
a lumen in between.1 That the NE would have two “walls” vs. 
the single lipid bilayer of the plasma membrane reinforced the 
basic functional view scientists had of this structure to protect 
the all-important genome. It has been proposed variously that 
the original evolution of the NE was a fortuitous consequence 
of the growth of tubular ER or plasma membrane invaginations2 
and that it enabled increasing genome complexity by supporting 
regulation and accurate segregation of a larger genome in mitosis.
The physical support to this nuclear “wall” is provided by 
the intermediate filament lamin polymer that underlies the 
INM. Lamins were the first identified NE proteins due to their 
abundance at ~3 million copies per mammalian nucleus.3 They 
form 10 nm wide filaments from the stacking of coiled-coil 
dimers in linear arrays,4 more like the fibers of a rope than the 
building block structure of actin filaments and microtubules. 
Though differing thus from rigid city walls this structure is 
actually stronger because actin filaments and microtubules will 
rupture under stresses that leave intermediate filaments, which 
can stretch to three times their length, intact,5 and so this 
structure may be of greater benefit to the nucleus as we now know 
it—a dynamic organelle under considerable mechanical pressures 
from chromatin on the inside and cytoskeletal connections 
on the outside.6 Lamins were likely the original intermediate 
filaments and are highly conserved in evolution among higher 
eukaryotes,7 but not so much as this stabilizing function: recent 
reports indicate that nucleated organisms previously thought to 
lack lamins such as Dictyostelium and Trypanosoma brucei have 
functional homologs with this coiled-coil based structure.8,9
The gates of the city are the nuclear pore complexes (NPCs), 
large macromolecular assemblies that form transport channels at 
places where the ONM bends in to fuse with the INM. NPCs are 
built from 30 core components, called nucleoporins or Nups that 
are present in multiple copies according to the 8-fold symmetry 
of the assembled structure.10
All the above appeared to be still consistent with the idea 
of the NE as just a protective barrier, but in a mediaeval city 
some of the most important activities, from the coordination of 
roads to the sentries to the markets and general commerce, took 
place at the walls or just inside the gates. Accordingly, a greater 
functional complexity for the NE began to be realized with 
the discovery that both the INM and ONM contain a variety 
of NE transmembrane proteins (NETs). The first NETs were 
identified starting in 1988 by microscopy screening, genetic and 
biochemical means, mostly based on associations with the lamin 
polymer. Novel NETs continued to be discovered at a pace of 
about one per year (reviewed in ref. 11) until their number grew 
exponentially with the application of proteomic approaches a 
little over a decade later.12,13 The study of NETs and lamins in the 
past 20 years has now linked the NE to functions ranging from 
cell and nuclear mechanical stability to cell cycle regulation and 
stem cell maintenance, signaling cascades, genome organization 
and gene expression.
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Nuclear envelope links to inherited disease gave the 
conundrum of how mutations in near-ubiquitous proteins 
can yield many distinct pathologies, each focused in different 
tissues. One conundrum-resolving hypothesis is that tissue-
specific partner proteins mediate these pathologies. Such 
partner proteins may have now been identified with recent 
proteome studies determining nuclear envelope composition 
in different tissues. These studies revealed that the majority 
of the total nuclear envelope proteins are tissue restricted in 
their expression. Moreover, functions have been found for 
a number these tissue-restricted nuclear envelope proteins 
that fit with mechanisms proposed to explain how the 
nuclear envelope could mediate disease, including defects in 
mechanical stability, cell cycle regulation, signaling, genome 
organization, gene expression, nucleocytoplasmic transport, 
and differentiation. The wide range of functions to which 
these proteins contribute is consistent with not only their 
involvement in tissue-specific nuclear envelope disease 
pathologies, but also tissue evolution.
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Lamins and several of the earlier discovered NETs have also 
been linked to many human diseases. These range from muscular 
dystrophies14-18 to lipodystrophies,19,20 cardiomyopathy,21 
neuropathy,22 dermopathy,23 osteopoikilosis (isolated, together 
with melorheostosis or as a symptom of Buschke-Ollendorff 
syndrome),24 dystonia,25-27 and premature aging syndromes.28-30 
The new NETs identified by proteomics may provide an answer 
to a conundrum regarding these diseases, namely how can 
mutations in near ubiquitous proteins in the NE cause diseases 
restricted to specific tissues? A potential resolution can be found 
in the “guilt by association” hypothesis that disease-causing 
mutations in relatively ubiquitous NE proteins might disrupt 
binding to as yet unidentified tissue-specific partner proteins 
to generate pathology in that particular tissue.31 This idea is 
supported by observations that many disease-linked NE proteins 
appear to function in complexes and that few have specific 
enzymatic functions themselves that could result in pathologies. 
Apart from the structural functions of the lamins and NETs of 
the SUN and nesprin families, the proteins thus far mutated 
in NE diseases have few inherent functions. Only LBR, which 
is mutated in the bone disorder Greenberg skeletal dysplasia,32 
has been shown to have an enzymatic activity—that of a sterol 
C-14 reductase.33 Other NETs linked to disease have no known 
enzymatic functions, but instead appear to influence a wide 
variety of activities through their binding partners, of which they 
have a great many.11 Indeed, observations that Emery-Dreifuss 
muscular dystrophy (EDMD) can be caused not only by lamin 
A mutations,15,17 but also by mutations in its interacting partners 
emerin14 and, at least indirectly, nesprins18 demonstrate that these 
proteins are part of larger complexes that yield disease when 
disrupted and support the “guilt by association” hypothesis. This 
idea is also supported by observations that NE-linked diseases 
tend to be genetically heterogeneous, with at least 19 variants 
described thus far for limb-girdle muscular dystrophy34 and 30 for 
Charcot-Marie-Tooth disease.35 If unidentified tissue-restricted 
components of large NE protein complexes do indeed mediate 
the tissue-restricted disease pathologies they could themselves 
potentially cause additional disease variants.
Nuclear Envelope Proteome  
Tissue Specificity
As a first step to attempt to identify candidate proteins that 
mediate tissue-restricted NE disease pathologies, new proteomic 
studies were undertaken on NEs isolated from different tissues. 
The first study determined the NE proteome of a lymphocyte-
enriched peripheral blood leukocyte fraction.36 Fluorescence 
activated cell sorting (FACS) revealed that the fraction was 
roughly 75% T-cells and helper T-cells. The cells from each 
blood donor were divided in two fractions. One was activated 
by treatment with phytohemagglutinin, because an enormous 
amount of dense peripheral chromatin can be observed by 
electron microscopy at the NE in the untreated cells and this 
largely dissipates upon such activation. Thus it was expected that 
some differences in protein composition at the periphery must 
occur to direct the visual differences in attached chromatin. 
Indeed, not only were there many proteins identified that had 
not been found in the original proteomic studies12,13 and which 
were preferentially expressed in blood or blood specific according 
to transcriptome data,37 but differences were observed in NET 
composition even between the two states of the same cells 
from the same donors (Fig. 2A). Moreover, in keeping with the 
idea that some of these differing proteins would contribute to 
chromatin organization, visual screens identified different sets of 
blood-specific NETs that could promote chromatin compaction 
or alter spatial genome organization.36
A second study used identical conditions for extractions and 
mass spectrometry to investigate the NE proteome of skeletal 
muscle.38 Whereas the lymphocyte nuclei are round and have 
a very large amount of dense peripheral chromatin, most of 
the muscle nuclei are ovoid, relatively flattened, and have an 
intermediate amount of dense peripheral chromatin. Moreover, 
there is a greater tendency for centromeres to be at the nuclear 
periphery in differentiated muscle cell nuclei,39 further suggesting 
that there would be differences in NE INM protein composition. 
There are likely to be differences in the ONM as well because 
the lymphocytes have a single nucleus and a relatively small 
cytoplasm whereas muscle cells are syncitial with many nuclei 
in an individual cell. The muscle NE proteome also included 
many proteins that were not found in other NE proteomic 
studies38 and, again, transcriptome analysis indicated that many 
of these proteins are either preferentially expressed in muscle or 
muscle-specific.
The liver NE proteome had been analyzed previously,13 but 
could not be directly compared with the leukocyte and muscle 
studies because these later studies had many more biological and 
technical replicates using more sensitive mass spectrometers as 
well as using multiple sequential proteolytic digestions, which 
was found to increase identification of transmembrane proteins 
presumably lost otherwise because of aggregation of hydrophobic 
regions. Thus, a third study used these same conditions to 
re-examine the proteome of liver NEs.40 The new liver NE 
proteome identified roughly 2½ times more proteins compared 
with the original study; however, these proteins for the most part 
were not ones found in the leukocyte and muscle studies. Instead, 
many were, like those found in the original study, preferentially 
expressed in liver according to the transcriptome data.37
The preferential tissue expression of many of the predicted 
transmembrane proteins identified in the three studies was 
directly confirmed by both RT-PCR and western blot where 
antibodies were available.40 Moreover, staining of rat tissue 
cryosections with these antibodies demonstrated that those 
found by proteomics only in a particular tissue yielded the 
characteristic “rim” staining of the NE only in that tissue, while 
only background staining was observed for the tissues where 
it was not found by the mass spectrometry (Fig. 2B). This 
confirmed both their tissue-specificity and their qualification 
as NETs.40 All in all, less than 20% of the total NE proteins 
identified and a similar number of the putative NETs identified 
were found in the NEs of all three tissues (Fig. 2C). This is 
especially remarkable given that none of the three tissues 
investigated represented a homogeneous population of single 
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cell types. Blood leukocyte-enriched populations were >75% 
lymphocytes, which were mostly T-cells and helper T-cells but 
also included cytotoxic T-cells and B-cells, yet the populations 
also included 5–20% myeloid cells. Muscle contains connective 
tissue, nerves and blood vessels, not just myocytes. Similarly, 
liver may be comprised of about 80% hepatocytes, but it also 
contains nerves and blood vessels, blood cells and fat cells. Thus, 
it might have been expected that the cell types shared between 
different tissues would bias the results toward overestimating 
the proportion of shared proteins among the sampled tissues. 
Many of the newly identified NETs appear to be very specific to 
the cell types and tissues in which they were found while others 
are expressed in a subset of tissues according to transcriptome 
data;37 for simplicity we will use the term “tissue specific” 
henceforth.
The unexpectedly high degree of tissue-specificity observed 
raised the concern that contaminants from other organelles 
might be contributing to the tissue differences. Such potential 
contaminants can be estimated based on proteome studies of 
other organelles and GO-functional/ subcellular localization 
annotations from the Gene Ontology database.41 The major 
membrane contaminants of NE preparations would be expected 
Figure 1. The mediaeval nuclear envelope. Historically the nuclear envelope (Ne) was viewed as little more than a barrier, like the walls of a mediaeval 
city. The Ne has a double membrane structure with inner (iNM) and outer (ONM) membranes and the ONM is continuous with the eR. An intermediate 
filament lamin polymer underlies the iNM, giving it stability, and is connected to the iNM by several Ne transmembrane proteins (NeTs). 
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Figure  2. Nuclear envelope proteome composition. (A) Differences in NeTs identified 
between unstimulated and PHA-activated states of the leukocyte Ne. (B) Staining of rat tissue 
cryosections with antibodies to different NeTs confirms their tissue specificity. C17orf62 was 
identified in all tissues and antibodies gave a nuclear rim staining confirming Ne residence 
in all three tissues. in contrast Tmem38A antibodies only give a nuclear rim staining pattern 
for muscle where it was uniquely identified, DHRS7 antibodies for liver where it was uniquely 
identified and Tmem126A antibodies for blood where it was uniquely identified. images taken 
with permission from Figure  5C in Korfali et al., 2012 Nucleus.40 (C) Less than 20% of NeTs 
identified in the three proteome studies of blood leukocytes, muscle and liver were found in 
all three tissues. Figure taken with permission from Figure 4A in Korfali et al., 2012 Nucleus.40 
(D) Comparison of Ne tissue variation with mitochondrial tissue variation. The percentage of 
the total proteins identified that were found in multiple tissues is plotted against the number 
of tissues. 
from the ER that is continuous with the NE 
and from mitochondria that can stick to NEs 
and also be caught in NE invaginations. Both 
of these organelles have been extensively 
investigated and their compositions have 
been determined by proteomics.42-44 Proteins 
identified in the NEs from different tissues that 
were known to associate with these potentially 
contaminating organelles accounted for 
slightly over 10% of all the proteins identified 
in the NEs; however, they were found in all 
tissues examined and so could not account for 
the tissue differences observed.40 In the case of 
ER contamination it is possible that, having 
not been specifically analyzed for tissue 
differences, tissue-specific ER contaminants 
are under-represented in the analysis; however, 
the behavior of so-called contaminants was 
the same for both ER and mitochondria and 
the mitochondrial proteome was determined 
from several different tissues. In fact, tissue 
differences were observed in the mitochondria 
study,43 but these were much smaller than those 
observed in the NE studies (Fig. 2D). Thus it 
is unlikely that the tissue differences observed 
in the NE proteome reflect tissue differences 
in expected contaminating organelles.
It is in fact more likely that the potential 
contaminants from these other organelles 
have separate roles in the NE as it has been 
estimated that 40% of proteins have multiple 
subcellular localizations.45 This idea is 
supported by the proteomics data in that if 
the proteins reflected contamination from 
the other organelles their relative abundance 
in the NE preparations should reflect their 
relative abundance within the organelles. 
However, spectral counts (a semiquantitative 
measurement of protein abundance used in mass spectrometry 
based on the number of times a particular peptide is recovered) 
for the ER and mitochondrial proteins found did not reflect 
their relative abundance within those organelles. Thus it is likely 
that many of these potential contaminants are indeed bona fide 
NE proteins.
Consistent with the likelihood that the identification of the 
first NE proteins reflected their relatively higher abundance, 
the NETs that were more tissue-specific were identified with 
far lower spectral counts than the first characterized ones. 
Lamins A/C and B1 were identified with 3772 and 2301 
spectra respectively and the number of spectra for the first 
NETs identified were 1826 for LAP1, 1473 for LAP2, 384 for 
LBR, 751 for SUN1, and 3184 for SUN2. Nurim and emerin 
were comparatively low with only 51 and 124 spectral counts 
respectively. In contrast, the vast majority of the new NETs 
identified and especially those identified in just one tissue had 
a spectral count lower than 20.40
Tissue-Specific Contributions to Disease Pathology
The possibility that some of the newly identified tissue-
specific NETs contribute to NE-linked disease pathologies is 
supported by some having already been linked to other similar 
inherited diseases (Table 1) and by the pathologies resulting from 
knockout in mice for others. Lamin A and the well-characterized 
and similarly widely expressed NETs emerin, nesprin1, nesprin 
2, and the soluble α splice variant of the NET LAP2 have all 
been linked to neuromuscular disorders, muscular dystrophies 
or cardiomyopathies. In addition the more tissue-specific NETs 
identified by proteomics of muscle NEs DTNA, VMA21, RYR1 
have also been linked to neuromuscular disorders, muscular 
dystrophies or cardiomyopathies. Thus these NETs could 
potentially mediate the tissue-specific pathologies of the diseases 
caused by the widely expressed NETs or potentially cause other 
variants of these diseases. Other muscle NETs like TMEM38A 
or Popdc2 are not linked to a disease thus far, but animal models 
underline their potential role in human muscular disease.
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VMA21 was identified only in the muscle NEs and confirmed 
to target to the NE. Mutations in VMA21—a gene encoding 
an essential assembly chaperone of the vacuolar ATPase—that 
result in haploinsufficiency cause a myopathy with excessive 
autophagy characterized by intracytoplasmic autophagic vacuoles 
with sarcolemmal features.46 Tmem38A was only identified in 
the muscle NE proteome, is both very preferentially expressed 
and abundant in muscle (194 spectra), and is in both the ONM 
and INM.38,40 Both Tmem38A and its related but more widely 
expressed homolog Tmem38B appear to function as a counter 
ion channel for calcium release, which is very important in 
muscle contraction. Studies knocking out both proteins together 
resulted in embryonic cardiac failure and dysfunctional skeletal 
muscle.47 Though less severe, the phenotype of knocking 
out just the muscle-specific TMEM38A was also focused 
in muscle, with defects in vascular smooth muscle function 
resulting in hypertension in intact mice48 and clear evidence 
of elevated Ca2+ pools in ex vivo muscle with a stronger initial 
contractile force followed rapidly by muscle fatigue.49 Another 
protein contributing to this nexus50 identified in the muscle 
nuclear membrane38,40 and confirmed to target to the NE51 is 
the ryanodine receptor 1 (encoded by RYR1) which serves as a 
calcium release channel. This protein also, unlike most of the 
tissue-specific NETs, was highly abundant with 235 spectra.38,40 
Mice carrying a homozygous targeted mutation in RYR1 died 
perinatally with skeletal muscle abnormalities.52 Mutations in 
Table 1. Confirmed NeTs associated with disease
Protein name
Gene 
name
ENSG number Associated disease
OMIM 
number
Reference
Tissue identified 
in (see ref. 40)
vMA21 vacuolar H+ -ATPase homolog VMA21 eNSG00000160131 Myopathy, X-linked, with excessive autophagy %310440 46 muscle
Ryanodine receptor 1 RYR1 eNSG00000196218
Central core disease of muscle #117000 53, 54
muscle
King-Denborough syndrome, Malignant hyperthermia  
susceptibility 1
#145600 55
Minicore myopathy with external ophthalmoplegia #255320 56
wolfram syndrome 1 (wolframin) WFS1 eNSG00000109501
wolfram syndrome #222300 62
muscleDeafness, autosomal dominant 6/14/38 #600965 60
wolfram-like syndrome #614296 61
Leucine rich repeat containing 8 
family, member A
LRRC8A eNSG00000136802 Agammaglobulinemia 5 #613506 67 blood
ATP-binding cassette, sub-family B 
(MDR/TAP), member 1
ABCB1 eNSG00000085563 inflammatory bowel disease 13 #612244 149 blood
epidermal growth factor receptor EGFR eNSG00000146648 Adenocarcinoma of lung, nonsmall cell lung cancer #211980 150 liver
ALG2, α-1,3/1,6-mannosyltransferase ALG2 eNSG00000119523 Congenital disorder of glycosylation, type ii #607906 151 liver and blood
Sequestosome 1 SQSTM1 eNSG00000161011 Paget disease of bone #602080 152 liver and blood
Magnesium transporter 1 MAGT1 eNSG00000102158
immunodeficiency with magnesium defect, epstein-Barr virus 
infection and neoplasia
#300853 153
liver and blood
Mental retardation, X-linked 95 #300716 154
Transmembrane protein 70 TMEM70 eNSG00000175606 Mitochondrial complex v (ATP synthase) deficiency, nuclear type 2 #614052 66 blood and muscle
eR lipid raft associated 2 ERLIN2 eNSG00000147475 Spastic paraplegia 18, autosomal recessive #611225 155 all tissues
Transmembrane protein 43 TMEM43 eNSG00000170876
Arrhythmogenic right ventricular dysplasia 5 #604400 156
all tissues
emery-Dreifuss muscular dystrophy 7 #614302 157
Lamin B receptor LBR eNSG00000143815
HeM skeletal dysplasia #215140 32
all tissuesPelger-Huet anomaly #169400 158
Reynolds syndrome #613471 159
Thymopoietin LAP2 eNSG00000120802 Cardiomyopathy, dilated, 1T #613740 160 all tissues
emerin EMD eNSG00000102119 emery-Dreifuss muscular dystrophy 1 #310300 14 all tissues
LeM domain containing 3 LEMD3 eNSG00000174106 Buschke-Ollendorff syndrome #166700 24 all tissues
Nesprin 1 SYNE1 eNSG00000131018
Spinocerebellar ataxia 8 #610743 161
all tissues
emery-Dreifuss muscular dystrophy 4 #612998 18
Nesprin 2 SYNE2 eNSG00000054654 emery-Dreifuss muscular dystrophy 5 #612999 18 all tissues
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RYR1 are associated with three myopathies: (1) Central core 
disease, a mild congenital myopathy characterized by delay of 
motor developmental and mild proximal weakness;53,54 (2) King-
Denborough syndrome, a myopathy with dysmorphic features 
and malignant hyperthermia susceptibility;55 and (3) minicore 
myopathy, a neuromuscular disorder pathologically defined by 
multiple areas of reduced mitochondrial oxidative activity along 
a limited extent of the longitudinal axis of the muscle fiber.56 The 
popeye domain containing protein Popdc2, identified in only the 
muscle NEs and confirmed in the INM,38 has been knocked out 
in multiple animal models. Morpholino-mediated knockdown of 
this NET in zebrafish resulted in aberrant development of skeletal 
muscle and heart57 whereas POPDC2 null mutant mice developed 
stress-induced bradycardia.58 Finally, though not yet tested for 
NE targeting, another NET identified only in the muscle NEs, 
DTNA (dystrobrevin), when mutated results in left ventricular 
non-compaction—a rare, unclassified cardiomyopathy.59
Not all disease-linked NETs identified in muscle make such 
clean associations with muscle disease: though only identified in 
the muscle NEs, mutations in the gene encoding WFS1 cause 
Wolfram syndrome characterized by optic atrophy, deafness,2 
and/or diabetes.60-62 However, this is not necessarily inconsistent 
with the matched tissue hypothesis because the NE proteome of 
eyes and ears was not determined. Indeed, transcriptome data 
indicate that while WFS1 is highly expressed in muscle, it is even 
more highly expressed in retina.37 The case of WFS1 is worthy 
of further note respecting the issue of subcellular localization. 
WFS1 was previously reported to localize primarily in the ER,63 
but is clearly also in the NE. Though WFS1 may have multiple 
cellular localizations and only be at the NE in certain tissues, 
the ER targeting was found by overexpression in heterologous 
HeLa and HepG2 cells63 that were not derived from tissues that 
express WFS1, and we have reported previously that heterologous 
overexpression of NETs can yield different subcellular 
localizations depending on the cell type used.64 Different 
subcellular localizations have clearly been shown for Tmem70, 
which was originally found to localize to mitochondria and be 
mutated in patients with mitochondrial complex V deficiency.65 
Tmem70 was found in both muscle and leukocyte NEs and 
according to transcriptome data are preferentially expressed in 
skeletal muscle, brain and blood.37 Not surprisingly, thus, it has 
also been linked to a neonatal encephalocardiomyopathy.66
Another tissue specific NET involved in a tissue specific 
disease was LRRC8A (Leucine-rich repeat-containing protein 
8A) that was only found in the blood leukocyte NEs. A mutation 
of LRRC8A resulted in a truncated protein inhibiting B-cell 
development.67 Thus muscle-specific NETs can cause muscle 
disease and blood-specific NETs can cause blood disease.
While the examples above make a reasonable case for some of 
these new tissue-specific NETs contributing to the pathologies 
of the diseases linked to widely expressed NE proteins, it should 
be noted that there are other possible mechanisms to achieve 
the tissue-specific pathologies. First of all, we have focused just 
on the NETs, but it is just as likely that soluble tissue-specific 
proteins that interact with the NE proteins mutated in disease 
could mediate the specific tissue pathologies. An example that 
could potentially explain emerin mutations causing EDMD is 
its binding to tissue-specific transcription factors. Emerin binds 
to the Lmo7 transcription factor that is expressed at high levels 
in muscle and heart and regulates a variety of muscle-related 
genes.68 Lmo7 has also been shown to be important for heart 
development in zebrafish,69 and so could easily be involved in 
EDMD pathology where heart is typically affected in addition 
to skeletal muscle. Emerin has also been shown to interact with 
Btf,70 a death-promoting transcriptional repressor expressed 
at high levels in blood.37 Not surprisingly, these soluble tissue-
specific proteins were also identified in the NE data sets along 
with many other potentially relevant transcriptional regulators. 
Yet another mechanism to achieve tissue-specificity is through 
tissue-specific splice variants. Mutations causing EDMD have 
also been identified in nesprin1α and nesprin2β—both small 
muscle specific isoforms of these NETs.18 We still do not know 
the full range of splice isoforms encoded by the SYNE (nesprin) 
genes, but based on those identified thus far it is likely that there 
will be many more. Finally, there could be differences in how the 
metabolic and physical function of different cell types intersects 
with the loss of a common NE function. However, countering 
this point is that even for the different lamin A-linked muscular 
dystrophies, where one could argue pathology is directed by the 
physical stress of muscle usage, there are differences in the specific 
muscle groups affected in the different diseases.71 Nonetheless, a 
combination of any of the above factors could work synergistically 
to direct pathology to a particular tissue. For example, though 
emerin and LAP1 are both near ubiquitously expressed, there are 
tissue differences in the actual level of expression. It was recently 
found that these two proteins work together to support skeletal 
muscle maintenance such that they could contribute together to 
muscle disease.72
Tissue-Specific Contributions  
to Cell Cycle Regulation
The basic regulation of the cell cycle through its stages (G
1
, 
S, G
2
, and M) is common for cells in all tissues. Nonetheless, 
cells in different tissues distinguish themselves by length, 
frequency, directionality and cause of induced cell divisions. 
These parameters can differ for cells in the same tissue or even 
the same cell type at different stages of differentiation such as 
in the layers of an epithelium. In fact the best-studied example 
of a NE link to the cell cycle is a complex that when disrupted 
in mice causes hyperproliferation of the progenitor layers of 
epidermis.73 This complex is formed from lamin A and LAP2α 
binding together to the retinoblastoma protein (pRb), a key 
cell cycle regulator.74,75 LAP2α is a soluble splice variant of the 
NET LAP2β. Disruption of this complex resulted in reduced 
pRb levels and a reduced capacity to undergo cell-cycle arrest 
in response to DNA damage76 or accumulation of pRb and 
G1 arrest77 depending on the cell type used. These results are 
consistent with the idea that the Lamin A/LAP2α complex 
both sequesters and stabilizes pRb so that, depending on the 
total milieu of cell cycle controls in a particular cell/ tissue type, 
different outcomes can be achieved.
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Though other mechanisms for how NE proteins can influence 
the cell cycle are less worked out, such influences are likely 
relevant to some NE-linked diseases. A lamin A mutant that 
causes EDMD yielded defects in myogenic differentiation when 
expressed in a mouse in vitro differentiation system, apparently 
because myoblasts become unable to exit the cell cycle which 
is a necessary prerequisite to form myotubes.78 Additionally, 
transcriptional fingerprints obtained from both emerin and 
lamin A-linked EDMD patients revealed that pRb pathways 
as well as MyoD pathways are impaired, suggesting disruption 
of cell cycle regulation and myogenic differentiation impairs 
muscle regeneration in the disease.79 This is also consistent 
with a doubling in the length of the cell cycle observed in tissue 
culture cells expressing some emerin mutations known to cause 
EDMD.80
One can actually envision many possible ways that NE 
proteins could affect cell cycle regulation. (1) The first is by 
direct interaction with cell cycle regulators such as has already 
been shown with pRb. In general, sequestration at the NE (and 
thus away from target genes) of any transcriptional regulator 
involved in the cell cycle would be expected to have profound 
effects. (2) A second mechanism by which the NE could 
influence the cell cycle is involvement in the transmission of 
signaling cascades from extra or intracellular signals into the 
nucleus. This could occur via NETs involved in signaling (see 
signaling section below) or by direct transport through the NPC. 
(3) Though the NE of higher eukaryotes is disassembled during 
mitosis, due to the many interactions of lamins and NETs with 
chromatin, failure to properly break these contacts could activate 
a checkpoint from lagging/ stuck chromosomes (see below). 
(4) NE proteins can also affect the success of mitosis through 
separate functions when the NE is disassembled. Lamin B and 
NPC-associated proteins contribute to spindle function during 
mitotic chromosome segregation.81,82 Tissue-specific NETs may 
also contribute as a subset of these is enriched at the spindle poles 
during mitosis (see later cytoskeletal section).38,83 (5) Finally, 
NETs could intersect with various cell cycle regulatory pathways 
or activate these pathways through mechanical stress or cancer 
activation. This latter mechanism is supported by recent findings 
with the tissue-specific NET4/Tmem53.84
NET4/Tmem53 was linked to the cell cycle in a FACS-
based screen of 39 newly identified NETs from the liver and 
leukocyte proteomic studies.13,36 Comparing the 2N DNA 
peak (representing the G
1
 phase of the cell cycle) with the 4N 
peak (representing G
2
/M) from FACS profiles between cells 
transfected with various NETs and untransfected cells in the 
same population revealed that NET4/Tmem53 expression 
promoted an accumulation of the 2N or G
1
 cell population.84 This 
effect was dependent on the master cell cycle regulator/ tumor 
suppressor protein p53 as re-testing exogenous expression of this 
NET in p53-/- cells not only lost the G
1
 accumulation effect, but 
actually switched it to a partial G
2
/M accumulation. The cell 
cycle effect was also lost in pRb deficient cells. Correspondingly, 
knockdown of TMEM53 resulted in a doubling of p53 levels, 
a 7-fold increase in p21, and a dramatic reduction in pRb 
phosphorylation without changes in overall levels of pRb. These 
effects are all consistent with a well-characterized pathway of 
signal propagation toward cellular senescence and indeed cell 
cycle withdrawal was confirmed as the endpoint for both NET4/
Tmem53 overexpression and knockdown. Testing for factors 
upstream of p53 revealed a dependency for all these effects on 
the p38 MAP kinase (mitogen-activated protein 14, MAPK14) 
that is involved in oncogenic activation and cellular stress.84 As 
NET4/Tmem53 is preferentially expressed in liver, it is possible 
that it is used for an added layer of cell cycle control that may 
be needed because liver is both a highly regenerative organ and 
the toxin sink for the body and this combination could easily 
lead to cancer transformation if the cell cycle is not both tightly 
controlled and responsive to stress. Alternatively, p38 activation 
could result from NET4/Tmem53 detecting physical stress or 
mechanical strain during liver regeneration.
The FACS-based screen also identified seven other NETs 
(NET11/Sccpdh, NET31/Tmem209, NET59/Ncln, Tmub1, 
Fam3c, Magt1, Tmem126A; Table 2) with an increased 
accumulation of 4N (G2/M) cells.84 Further testing revealed 
that the effect of all these NETs except for NET59/Ncln was 
independent of p53, suggesting that they are more likely to be 
affecting M phase of the cell cycle or operate through a completely 
novel mechanism. As no significant mitotic abnormalities were 
observed during the screen, it seems most likely that these 
cells arrest in G
2
 in a p53-independent manner85 opening the 
exciting possibility that they activate a differentiation program 
through the regulation of cell cycle exit. This fits with the fact 
that, like NET4/Tmem53, most of these NETs were very tissue 
specific37 and thus might be expected to have tissue-specific cell 
cycle effects. It is therefore not too surprising that in a separate 
study NET31/Tmem209 was found to function together with 
the nucleoporin Nup205 to increase nuclear levels of c-myc and 
this may explain the role of increased NET31/Tmem209 levels 
specifically in lung cancers.86 That roughly 20% of the new 
NETs tested had effects on the cell cycle suggests that these types 
of tissue-specific modifying functions may be quite prevalent.
As noted above, failure to properly disassemble the NE in 
prophase or reassemble it in telophase could prevent successful 
mitosis. NE disassembly is driven by phosphorylation of lamins, 
NETs and nucleoporins to release their associations with 
chromatin.87-91 Failure to fully disengage NE proteins from 
chromatin could result in blocking of microtubule attachments to 
kinetochores resulting in lagging chromosomes and aneuploidy. 
Correspondingly, NE reassembly is driven by dephosphorylation 
of these NE components; however, unlike disassembly where 
lamins play a driving role, the NETs and nucleoporins appear 
to dominate reassembly. This is because many NETs bind 
chromatin and DNA (reviewed in ref. 92) so that they can 
direct the membranes in which they are inserted to the mitotic 
chromosomes. The NET Lem4 (ANKLE2) promotes the 
dephosphorylation of the chromatin protein BAF by inhibiting 
BAF’s mitotic kinase NHK-1/Vrk-1 and simultaneously 
recruiting its phosphatase PP2A.89,93 The widely expressed NETs 
Lap2β, emerin and MAN1 through binding BAF have been 
shown to be instrumental in reforming the NE by reinstating 
chromatin-NE interactions.94 However, the new tissue-specific 
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NETs are likely to contribute as much to this process because 
their nucleoplasmic regions tend to have high isoelectric points 
for binding the negatively charged DNA95 and several of these 
tissue-specific NETs have been found to reposition chromosomes 
(see later chromosome repositioning section).96
Tissue-Specific Contributions to Signaling
The NE has to pass signals from a variety of signaling 
cascades to the genome to trigger changes in gene expression 
in response to various cellular and extracellular cues. In most 
cases signals were thought to pass into the nucleus through the 
NPC by regulated transport of activated transcription factors or 
other regulators that would activate transcription factors already 
in the nucleus. However, several widely expressed NETs have 
now been linked to a handful of signaling pathways. Analysis 
of changes in transcription profiles between heart from a wild-
type or an emerin-null mouse revealed emerin connections to 
10 signaling pathways, including Wnt and TGFβ pathways and 
MAPK and JNK kinase cascades97,98 and in skeletal muscle myoD 
and pRb pathways were affected.99 One possible explanation of 
emerin’s effect on a plethora of pathways, as well as on myogenic 
differentiation, is disruption of miRNA expression in emerin-
null cells.100 Emerin was also shown to bind β-catenin and 
through it affect the Wnt signaling pathway.101 This crosstalk 
between emerin and β-catenin influences adipogenesis102 so 
that, though widely expressed, emerin plays significant roles in 
multiple differentiation pathways. Interestingly, ONM resident 
nesprin-2 interacts with α-catenin and together they form 
complexes with emerin and β-catenin.103 The widely expressed 
NET MAN1 has separately been shown to affect Smad/BMP/
TGFβ signaling.104-106 The initial model from this data was that 
 Table 2. Novel NeT functional groupings
NET Liver spectra Muscle spectra Resting leuk spectra Activated leuk spectra Reference
Cell Cycle
NeT4/Tmem53 3 0 0 0 84
NeT11/Sccpdh 118 6 2 4 84
NeT31/Tmem209 537 34 17 11 84
NeT59/Ncln 75 0 16 12 84
Tmub1 31 0 2 5 84
Fam3c 0 0 6 5 84
Magt1/iAG2 7 0 4 2 84
Tmem26a 0 0 17 0 84
Signaling
NeT59/Ncln 75 0 16 12 108
NeT25/LeM2 18 47 14 12 109
NeT39/Ppadc3 3 0 0 0 110
NeT45/Dak 1 0 6 1 111
NeT13/Smpd4 644 101 19 20 112
NeT37/KiAA1161 5 6 0 0 113
Cytoskeleton
NeT5/Tmem201 105 163 10 2 83,126
KLHL31 0 4 0 0 38
Tmem214 100 22 10 13 38
wfs1 0 40 0 0 38
Gene Organization
STT3A 130 8 14 20 36
TAPBPL 4 0 6 5 36
NeT29/Tmem120A 2 0 0 0 96
NeT39/Ppadc3 3 0 0 0 96
NeT5/Tmem201 105 163 10 2 96
NeT45/Dak 1 0 6 1 96
NeT47/TM7SF2 106 5 0 6 96
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MAN1 binding to Smads simply sequestered this part of the 
signaling pathway at the nuclear periphery, away from targets in 
the genome, thus inhibiting BMP/ TGFβ signaling. However, 
from recent work it turns out that MAN1 directly competes 
with the transcription factor FAST1 for binding to Smads and 
then additionally recruits the phosphatase PPM1A to inactivate 
the bound Smads, thus delivering a double whammy knockout 
blow to the signaling pathway.107 A less direct intersection 
with TGFβ signaling pathways appears to exist for one of the 
new NETs that was found to influence cell cycle progression: 
NET59/Ncln has been reported to form an ER-based complex 
with NOMO that antagonizes Nodal signaling and so affects 
TGFβ pathways.108
Several other NETs identified in the NE proteomics studies 
have since been linked to various signaling pathways (Table 2). 
NET25 (Lem2), a paralog of MAN1, was also widely expressed, 
but was found to be required for efficient myoblast differentiation. 
NET25 is able to complement emerin’s role in myogenesis, and, 
like emerin, it negatively regulates the ERK1/2 pathway.109 
NET39 also affects a common kinase signaling pathway, but 
is very tissue-restricted in expression being highly expressed 
in heart and skeletal muscle37 and strongly induced during 
C2C12 mouse myogenic differentiation.110 NET39 is a member 
of the LPP family of membrane lipoprotein phosphatases. 
Its knockdown promoted myogenesis and its overexpression 
inhibited C2C12 differentiation.110 NET39 was further found 
to interact with mTOR and it is thought to act on this signaling 
pathway in C2C12 myogenesis.110 Another tissue-specific NET, 
NET45/DAK is highly liver specific and a member of the 
evolutionarily conserved family of dihydroxyacetone kinases. It 
has been shown to interact with MDA5, a cytoplasmic sensor 
of viral RNA. MDA5 activates expression of interferon-β and 
is essential for the innate immune response. Overexpression 
of DAK negatively regulated MDA5-induced interferon-β 
expression and its knockdown increased interferon-β levels 
upon viral infection.111
Very dissimilar signaling pathways have been linked to other 
NETs. NET13/SMPD4 is a member of the sphingomyelin 
phosphodiesterase family. Such proteins are linked to many 
different lipid signaling pathways.112 Though far from tissue-
specific, NET13/SMPD4 is extremely variable in expression 
being absent from roughly half of tissues in a large transcriptome 
study.37 NET37 is preferentially expressed in muscle and 
a member of family 31 glycosidases. It is highly expressed in 
skeletal muscle and upregulated during C2C12 myogenic 
differentiation. Its knockdown reduces C2C12 differentiation 
potential by half and its catalytically dead mutant failed to 
rescue this phenotype, consistent with an important role for 
this INM-anchored glycosidase in myogenesis.113 NET37 
interacts with the IGF-II precursor and is required for IGF-II 
secretion. Through this it positively regulates the Akt pathway 
in C2C12 differentiation.113 As more novel tissue-specific NETs 
are tested it seems likely that more such signaling pathways will 
be uncovered. Notably, unlike most of the original identified 
NETs, many of these appear to have enzymatic functions to 
contribute to these processes.
Possible Tissue-Specific Contributions  
to Cytoskeletal Organization  
and Mechanical Stability
The intermediate filament lamins and the widely expressed 
NET SUN and nesprin proteins have been shown to contribute 
to nuclear mechanical stability in experiments measuring 
resistance to applied mechanical forces.6,114 The transmembrane 
SUN proteins in the INM bind to the lamin polymer via their 
nucleoplasmic region while their lumenal region is part of a 
connection to the lumenal region of transmembrane nesprins 
in the ONM. Together this nexus is called the Linkers of 
the Nucleoskeleton to the Cytoskeleton or LINC complex 
(Fig. 3).115 The cytoplasmic regions of most nesprin isoforms 
include an actin-binding site to connect to the cytoskeletal 
actin microfilaments. There is also indirect evidence that LINC 
might be able to also connect to other cytoplasmic filaments as 
nesprin 3 binds plectin,116 which can indirectly connect to all 
cytoplasmic filaments, and microtubule motors have been found 
to associate with some nesprin isoforms117,118 (Fig. 3). Some 
have also proposed that emerin be considered as an additional 
LINC complex component.119 The LINC complex is involved 
in a number of cellular functions including nuclear positioning, 
mechanotransduction, cell division and the organization of 
the cytoskeleton (reviewed in ref. 119). Disruption of LINC 
complexes induces an overall loss of mechanical stiffness across 
the cytoskeleton.120 LINC complex components and possibly the 
complex itself are additionally important for telomere positioning 
through SUN proteins121 and for association of the centrosome 
with the nuclear membrane through emerin.122
Although LINC is highly conserved, it is possible that tissue 
specific proteins interact with the complex and there is even some 
tissue specificity from orthologs and splice variants within the 
core LINC components. There are five SUN proteins of which 
SUN1 and 2 are widely expressed while SUN3, 4, and 5 are testis 
specific. There are four nesprins with many splice variants, and 
those shown to be involved in EDMD are muscle specific.18 The 
nesprin effects in muscle dystrophy could be due to mechanical 
instability or also to disruption of nuclear positioning under 
the neuromuscular junction. Both a dominant-negative nesprin 
mutant and nesprin 1 and 2 double knockout mice fail to 
recruit synaptic nuclei to the neuromuscular junction in skeletal 
muscle.18,123 In skeletal muscle, levels of nesprin1 in general are 
highest in synaptic nuclei,124 further supporting tissue specificity 
of function.
Transmembrane Actin-associated Nuclear Lines or TAN 
lines (Fig. 3) are a subset of actin filaments that direct nuclear 
positioning in migrating cells through connections that involve 
LINC complex proteins nesprin2-giant and SUN2.125 A potential 
tissue-specific component has recently been added to the TAN 
lines in that NET5/Samp1 was found to contribute to stabilizing 
the interaction between the TAN lines, LINC proteins and 
the nuclear lamina.126 This function is assisted by the fact that 
NET5/Samp1 has been shown to bind lamin A/C, emerin, 
SUN1, and SUN2.127 NET5/Samp1 also may play a role in 
aspects of cell polarity as its knockdown results in an increase 
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in the distance between the NE and the centrosome.83 These 
different aspects of NET5/Samp1 function may be directed 
in part by different tissue-specific splice forms observed using 
NET5 antibodies.96 Several NETs identified in the muscle NEs 
were found in a visual screen to affect aspects of cytoskeletal 
organization (Table 2).38 Of particular note, two of these muscle 
NETs appeared to track with microtubules at the nuclear surface, 
suggesting that there may be another type of LINC complex 
formed by different NETs that is more specific for microtubule 
connections. Given the promiscuous interactions of SUN 
domain proteins and nesprins,120 it is likely that tissue-specific 
expression of their isoforms as well as potential interactions with 
tissue-specific NETs, as already shown for NET5/Samp1, may 
play an important role in the spatial and temporal control of 
nucleo-cytoskeletal coupling.
Tissue-Specific Contributions  
to Genome Organization and Gene Expression
It has been clearly shown that specific chromosomes, 
chromosome regions, and chromatin domains have preferred 
positions in the interphase nucleus and it is thought that this 
may function to optimize gene regulation. For example, both 
microscopy and biochemical approaches indicate that the gene-
poor (and mostly transcriptionally inactive) chromosomes tend 
to be at the nuclear periphery while gene-rich (and mostly 
transcriptionally active) regions locate to the interior (reviewed 
in128). Though most chromosomes follow this general tendency 
for gene poor chromosomes to be at the periphery, the spatial 
organization of genes and chromosomes can also be tissue or 
cell-type specific. Particular genes or chromosomes tend to be 
found in the nuclear interior in one cell type while being at the 
periphery in another (reviewed in ref. 128).
The NE is thought to be one of the major drivers of 
chromosome and gene positioning within the interphase nucleus 
due to the fact that mutations in or loss of NE proteins (i.e., 
lamins and NETs) can result in altered spatial chromosome 
organization (reviewed in ref. 128). The effects of widely 
expressed NE proteins on chromosome positioning likely 
reflects the general tendency for gene poor chromosomes to be 
at the periphery driven by interactions between lamins and core 
histones129 and several NETs that bind silenced chromatin. For 
example LBR binds heterochromatin protein 1 (HP1)130 and 
LAP2β binds the transcriptional repressor germ-cell less131 and 
histone deacetylase 3 (HDAC3).132 Accordingly, recent studies 
have shown these proteins to function in generic aspects of 
spatial genome organization through an interaction with lamin 
B1, LAP2β, and HDAC3133 and general peripheral positioning of 
heterochromatin through LBR.134
The mechanism for achieving tissue-specific patterns of 
spatial genome organization is expected to also function through 
affinity tethering, but the players have until recently remained 
obscure. However, with the identification of so many tissue-
specific NETs a visual screen was recently engaged that found 
Figure 3. Nucleoskeleton and nuclear envelope connections to the cytoskeleton. The LiNC complex is comprised of SUN and nesprin NeTs that connect 
the inner (iNM) and outer (ONM) nuclear membranes across the nuclear envelope lumen. From the iNM SUN proteins connect to the intermediate 
filament lamin polymer and from the ONM the nesprins connect to actin microfilaments and possibly indirectly to other filament systems. emerin has 
been proposed to function together with the LiNC complex as might other as yet unidentified proteins among the tissue-specific NeTs. A similar complex 
connects to TAN-lines that operate like train tracks on which the nucleus migrates to be in line with the leading edge during cell movements. The 
somewhat tissue-restricted NeT5/Samp1 has been shown to function together with this complex as, again, may other tissue-specific NeTs. Some muscle 
NeTs tracked with microtubules at the nuclear surface suggesting the possibility of another complex like LiNC directed specifically for microtubules. 
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that several extremely tissue-specific NETs could reposition 
chromosomes to the nuclear periphery (Table 2).96 Each of these 
NETs affected just a subset of chromosomes and different NETs 
affected different combinations of chromosomes, suggesting that 
each NET has different binding sites on DNA/chromatin that 
can function synergistically so that in combination they can 
achieve a threshold of affinity to move an entire chromosome 
to the periphery. For example, in liver cells only a liver-specific 
subset of NETs is expressed (NET45 and NET47 and possibly 
others). This particular combination of NETs is not expressed 
in other cell types such as fibroblasts. This results in capturing 
of a particular chromosome set at the nuclear periphery in liver 
cells but not in fibroblasts (Fig. 4A and B). As several tissue-
specific NETs were also found for other tissues such as muscle, 
one could imagine that as progenitor cells choose their eventual 
fate between a muscle and fat cell lineage that changes in NET 
composition could likewise engineer a particular pattern of 
spatial genome organization specific to that tissue that could also 
contribute to its differentiation (Fig. 4C). Though it is not yet 
known whether these tissue-specific NETs bind DNA, chromatin 
proteins or transcriptional regulators sitting on particular genes, 
secondary structure predictions indicate that many have coiled 
coils or leucine zippers that could be used in interactions with 
transcriptional regulators and some, such as NET5/Samp1,127 
have zinc fingers that could be used for direct binding to specific 
DNA sequences.
The effects of this repositioning on gene expression are still 
under investigation, but there are several intuitive mechanisms 
whereby gene expression could be changed through gene 
positioning. (1) Local propagation of silencing to new 
genes recruited to the same general position due to the local 
abundance of silencing enzymes, for example the affinity of 
HDAC3 for LAP2β.132 This mechanism could also work in the 
opposite direction with propagation of activation as the protein 
originally identified as NET43, now known as hALP1, only 
has a predicted transmembrane span in certain species, but in 
humans where it lacks this it can be recruited to the NE through 
binding to SUN1 at the end of mitosis where it facilitates the 
decondensation of chromatin.135 (2) Increasing the effective 
concentration of a particular transcriptional regulator through 
compartmentalization could also alter gene expression. The 
NE represents ~1/30th the volume of the nucleus, so LAP2β 
recruitment of germ-cell less131 could make its local concentration 
30-fold higher than the actual concentration in the whole nucleus. 
Similarly, transcription factors could be sequestered away from 
targets in the genome as was shown for MAN1 and Smads.104,105 
(3) Steric factors blocking access to the DNA for transcriptional 
activators or alternatively in the structure of tethered chromatin—
still unknown—could enable greater access to the local epigenetic 
silencing enzymes or transcriptional repressors. Testing these 
various possibilities is hindered by the fact that, when genes 
move in a physiological context such as differentiation, many 
additional changes occur within the time frame researchers are 
able to sample such as the pattern of transcriptional regulators, 
epigenetic marks on the chromatin, the transcriptional state of 
the gene, etc. The inability to modulate gene position without 
the myriad physiological and developmental changes has resulted 
in the exclusive use of artificial tethering systems to address 
this question with resulting contradictory findings (reviewed in 
ref. 128). We anticipate that the recent identification of 
endogenous players in this process—the tissue-specific NETs 
that alter chromosome and gene positioning—will in the next 
years enable clear answers to this question.
Tissue-Specific Contributions  
to Nucleo-Cytoplasmic Transport
The NPCs are arguably the largest protein complex in the cell 
and were originally weighed in at ~125 MDa by cryo-electron 
microscopy studies.136 However, proteomic studies that identified 
roughly 30 core component proteins only account for a mass of 
~40 MDa for the yeast NPC and ~60 MDa for the mammalian 
Figure  4. Tissue-specific radial chromosome organization can be 
mediated by tissue-specific NeTs. (A) Distinct spatial chromosome 
arrangements can be achieved by the differential expression of tissue-
specific NeTs that have been shown to each reposition partially distinct 
yet overlapping sets of chromosomes to the nuclear periphery. The red 
and blue colored chromosomes are at the nuclear periphery in liver cells 
because liver-specific NeTs that have affinity to these chromosomes 
are expressed. These liver-specific NeTs are not expressed in fibroblasts 
resulting in a more internal localization of the same chromosomes. (B) 
Affinity principle of NeT-mediated chromosome positioning. Human 
chromosome 5 is preferentially internal in fibroblasts but in a cell 
type such as heart where NeT47 is weakly expressed might have weak 
affinity for the periphery. in liver, where NeT47 and NeT45 are both 
strongly expressed, chromosome 5 would have a stronger affinity for 
the periphery. (C) The same principle could apply during differentiation 
where the same progenitors can develop into muscle or fat cells, each of 
which has differences in the milieu of NeTs expressed and differences in 
the pattern of radial gene and chromosome positioning. 
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NPC.10,137 This discrepancy has generally 
been attributed to the addition of transport 
receptors and their substrates that transiently 
associate with the NPC core structure in the 
process of translocating through the NPC 
central channel, but it is also possible that 
there are as yet unidentified NPC components 
some of which may be tissue specific.
The first indications of tissue-specificity 
in the NPC came from observations of tissue-
specific expression of transport receptor 
variants (reviewed in ref. 138). Chief among 
these is the importin-/karyopherin-α family, 
which is encoded by multiple genes that 
each produces multiple tissue-specific splice 
variants. Some of these splice variants have 
been shown to play important developmental 
roles,139 and this is likely due to their favoring 
transport of developmentally important 
nuclear regulators.
It was not long after the first reports of 
tissue-specific transport receptors that the 
transmembrane nucleoporin gp210 (also called 
POM210) was cloned in a study comparing 
uninduced to induced mesenchyme.140 This 
was the first demonstration of cell type and 
developmental specificity in expression of a core 
component of the NPC. This developmental 
and tissue-specificity was later confirmed in a 
wider study in mouse that directly compared 
it to other nucleoporins POM121 and Nup62 
that were expressed in all tissues examined.141 
More recently it was found that gp210 is 
important for both myogenic and neuronal 
differentiation.142 This followed on work 
showing that Nup133 is important for neural 
differentiation in mice143 and that Nup358/
RanBP2 also changes during myogenesis.144 
This latter study is perhaps the most telling 
as here it was found that Nup358/RanBP2 
levels increase during myogenesis concomitant 
with a change in the physical architecture of 
the cytoplasmic filaments of which Nup358/
RanBP2 is a primary component.144 This 
suggests that differences in the physical/
mechanical needs of differentiated muscle 
require either a sturdier cytoplasmic face to 
the NPC or that a requirement for a higher 
metabolic load enlists more filaments to 
capture cargos. Tissue-specific variants of 
Nup358/RanBP2 and POM121 have also 
been observed as well as altered expression and 
splicing for Nup98/96.145-147
It remains to be seen whether any of these 
new NE proteins are tissue-specific components 
of the NPC, but it is noteworthy that 
Figure 5. evolutionary conservation of tissue-specific and widely-expressed NeTs. Orthologs 
based on eNSeMBL annotations are plotted as a heat map for new NeTs identified in the 
various tissue proteomic studies. NeTs identified only in the blood Nes, only in the liver Nes, or 
only in the muscle Nes are clustered as well as a group of NeTs identified in all three. The color-
coding from yellow to blue indicates decreasing sequence identity of the orthologs and red 
indicates no ortholog was present in a particular organism. There is clearly more conservation 
among the NeTs that were found in all three tissues, but even more interestingly clear breaks 
in the conservation of NeTs through evolution can be observed. Some loss can even be found 
between humans and other primates, another break occurs between primates and other 
mammals. Then within mammals some additional breaks can be observed, particularly with 
regards marsupials. A larger loss of orthologs occurs going into reptiles and fish and birds are 
even more remote from humans. Finally, the lower eukaryotes have very few NeT orthologs. 
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stretches of phenylalanine-glycine (FG) motifs in unstructured 
regions containing prolines are a characteristic feature of many 
nucleoporins and the NE data sets were strongly enriched for these 
motifs.95,148 Moreover, the third mammalian transmembrane 
nucleoporin NDC1 was not found in the NPC proteomics,10,137 
but was identified in the NE proteomics studies.13,36,38,40 Together 
these observations argue for at least a reasonable possibility that 
additional uncharacterized nucleoporins and transport receptors 
can be found in these data sets.
Potential Tissue-Specific Contributions  
to Tissue Differentiation and Evolution
Any of the above-discussed functions linked to tissue-specific 
proteins could have effects on overall tissue differentiation 
and function. Tissue-specific NETs that play roles in cell 
cycle regulation could, if defective, reduce the abundance of a 
particular cell type within a tissue and the ability of the tissue to 
regenerate when damaged. Defects in signaling, spatial genome 
organization and gene regulation from tissue specific NETs 
could modulate tissue-specific gene expression and the overall 
metabolism supported by the altered genes. Loss of a tissue-
specific NET contributing to cytoskeletal organization could 
yield defects in the establishment of cell polarity, affecting the 
efficiency of polarized secretion in the tissue.
In all of the above-mentioned cases, the tissue could 
conceivably carry defects while retaining the outward appearance 
of normalcy. The transcription factors driving differentiation and 
gene expression would still be there, the core of the LINC complex 
would still provide basic cell mechanical functions, basic nucleo-
cytoplasmic transport would still occur. We postulate that the 
roles of tissue-specific NETs is to fine tune cell functions so that, 
for example, in some NE-linked diseases loss of an interaction 
with a tissue-specific NE protein could yield subtle defects that 
only become pronounced when a muscle is repeatedly stressed or 
a fat store is called upon to manage a heavier metabolic load. Any 
athlete can attest that the metabolic and physical loads we normally 
place on muscle in an average day are minimal compared with the 
kind of demands placed on the same muscle groups in an athletic 
competition. Accordingly, the timing of clinical presentation in 
many NE-linked diseases—when children begin to become more 
active physically or upon puberty when higher usage, metabolic 
or endocrine loads would be placed on the tissue—is consistent 
with this idea of defects in tissue-specific NETs resulting in failure 
to achieve optimal gene expression or metabolism while initially 
giving the appearance of normal development.
It is intriguing to speculate that this fine-tuning by tissue-
specific NETs helped drive organism complexity. Comparison of 
the evolutionary conservation of all the NETs identified in the 
various proteomic analyses revealed that the more tissue-specific 
NETs were the least evolutionarily conserved.40 Thus, the 
tissue-specific NETs evolved as organisms began to distinguish 
more complex tissues and tissue functions. Interestingly, when 
searching for orthologs in a wide range of eukaryotes whose 
genomes have been fully sequenced and annotated, we observed 
enormous variation even in closely related organisms (Fig. 5). 
The red on the heat map indicates no ortholog to the human 
NET and some human NETs did not even have orthologs in 
other primates. A sharp drop in the organisms having orthologs 
of NETs occurs when leaving primates to other mammals with 
another sharp drop between mammals such as dog, horse and 
dolphin and mammals such as wallaby, alpaca and platypus 
(Fig. 5). Yet another sharp drop is observed with birds, and, 
interestingly, there is more ortholog identity between humans 
and fish and reptiles than between humans and birds. Very few 
NET orthologs were found in lower eukaryotes including some 
of the most commonly used model organisms of worms, flies 
and yeast (Fig. 5). While these lower eukaryotes are excellent 
to study the core components of these systems such as the core 
LINC complex or core NPC, the full functional complexity will 
only be able to be properly addressed in human tissues.
This evolutionary analysis also indicates some interesting 
outliers that might be worth investing in as model systems to 
study family complexity. Because of their association in the 
LINC complex one might think that nesprins would co-evolve 
with SUN proteins. However, based on ENSEMBL data, in fish 
nesprins have twice the normal number of orthologs in mammals 
while SUN proteins have half the number. Chickens on the other 
hand have jumped from the normal mammalian number of 
4–6 SUN protein genes to 16. Understanding what advantage 
trebling the number of SUN proteins has to chickens when other 
gene families have not similarly expanded may help to understand 
fully the functions of this interesting protein family.
The three tissues from which these NE proteomes were 
determined were chosen because they have widely differing 
characteristics; however, there is still a need for other tissues to be 
examined. Interestingly, when testing NET expression in various 
tissues skin was lacking in many of the more widely expressed of 
the novel NETs.40 We anticipate that there are likely to be large 
numbers of additional tissue-specific NETs found in skin, brain 
and germ cells based on this analysis; however, for any tissue 
linked to disease it makes sense to engage proteomic analyses to 
identify its most tissue-specific NETs.
Conclusions
Our view of the NE has in the past 20 years evolved from 
that of little more than a physical wall to a dynamic structure 
perhaps even more complex than the plasma membrane in its 
responses in signaling and its variety of functions. Though this 
review has focused on the more tissue-restricted NETs with less 
characterized enzymatic functions, there were also many well 
characterized membrane proteins identified at the NE that have 
functions in ion transport, membrane biogenesis, proteolysis 
and dozens of other functions also relevant to this organelle. 
In retrospect, this is not surprising when considering that the 
NE must integrate signals from all over the cell and even from 
outside the cell to rapidly respond to a wide range of stimuli with 
changes in gene expression, protein and mRNA degradation, 
initiation or escape from the cell cycle, nuclear size, nuclear and 
cell migration, etc. The various tissue NE proteome data sets are 
rich with information that can be applied to all these functions.
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